ArticleEndocrinology, diabetes & metabolism case reports2021
Primary hepatic neuroendocrine tumor.
Article in Endocrinology, diabetes & metabolism case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 17 citations in OpenAlex.
- Ectopic Cushing's syndrome. A metastatic hepatic neuroendocrine tumour: case report and literature review.Journal of surgical case reports · 2026Article
- Rapid Progression of Primary Hepatic Neuroendocrine Carcinoma: A Case Report Demonstrating Drastic Oncological Behavior.The American journal of case reports · 2025Article
- A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties.Life (Basel, Switzerland) · 2025Article
- Unusual liver tumors: spectrum of imaging findings with pathologic correlationDiagnostic and interventional radiology (Ankara, Turkey) · 2025Review
- Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity.ACG case reports journal · 2024Article
- Case report: Recurrence of primary hepatic neuroendocrine tumors after resection of liver segments IV in 8 years follow-up.Frontiers in medicine · 2024Article
- Primary hepatic functional neuroendocrine tumor in an elderly female: Case report.Clinical case reports · 2024Article
- Primary hepatic neuroendocrine neoplasms: imaging characteristics and misdiagnosis analysis.Frontiers in oncology · 2024Article
- A rare primary hepatic neuroendocrine tumour with laparoscopic resection: a case report.Journal of medical case reports · 2023Article
- Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review.Frontiers in oncology · 2023Article
- Comparison of primary hepatic neuroendocrine tumors and non-hepatitis B non-hepatitis C hepatocellular carcinoma on contrast-enhanced ultrasound.Frontiers in oncology · 2023Article
- Article
- Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.Frontiers in medicine · 2022Article
- Primary hepatic neuroendocrine neoplasm (with video).Endoscopic ultrasoundArticle
- New Pathological Insights into Biomarkers for Multimodal Therapeutic Approach in Hepatic Neuroendocrine Tumors: A Detailed Case Report.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summaryPrimary hepatic neuroendocrine tumor (PHNET) is a rare type of neuroendocrine tumor (NET) that is also a primary hepatic tumor. Patients are present with almost no specific clinical symptoms and typically present with negative test results and atypical imaging characteristics; therefore, the differentiation of PHNET from other types of primary hepatic masses can be very difficult. In this article, we describe a case of PHNET that mimicked a liver helminth infection in a 57-year-old man. The diagnosis of PHNET in this patient was challenging, and the final diagnosis was based on imaging, histopathology features, and long-term follow-up. LEARNING POINTS: An uncommon type of neuroendocrine tumor (NET) is a primary hepatic neuroendocrine tumor (PHNET). Primary hepatic neuroendocrine tumors are rare NET lesions found in the liver, characterized by non-specific clinical and imaging results, which can be easily confused with other liver lesions, including HCC and parasitic lesions. To have a conclusive diagnosis and classification, a mixture of many medical assessment techniques, such as imaging, gastrointestinal endoscopy, nuclear medicine, anatomy, including histopathology, and immunohistochemistry, is essential.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.